Nov 4, 4:16 PM ET
Corpay, Inc. reported third-quarter 2026 results featuring an 18% increase in revenues to $1.38 billion and a 32% increase in adjusted net income per diluted share to $7.54. Driven by strong operational performance, management raised its full-year 2026 financial outlook, projecting revenue of approximately $5.35 billion at the midpoint. Shareholders also benefited from ongoing share repurchases totaling $1.85 billion through the end of the quarter.
- Revenues grew 18% year-over-year to $1,381.9 million for the third quarter ended September 30, 2026.
- Adjusted net income per diluted share increased 32% to $7.54 for the third quarter of 2026.
- Full-year 2026 guidance was raised to a midpoint of $5.35 billion in revenue and $28.00 in adjusted net income per diluted share.
- The company repurchased 5.25 million shares for $1.85 billion through the end of the third quarter of 2026.
Read the filing on SEC.gov ↗
Aug 5, 4:13 PM ET
Corpay reported second-quarter 2026 revenue of $1.34 billion, up 21% from a year earlier, and adjusted EPS of $7.00, up 36%. GAAP net income fell 13% to $248.3 million after a $100 million charge for a preliminary FTC settlement, and the company raised its full-year 2026 revenue and adjusted EPS guidance.
- Q2 2026 revenues rose 21% to $1,338.8 million; GAAP diluted EPS fell 7% to $3.70 from $3.98.
- Adjusted net income per diluted share rose 36% to $7.00 from $5.13; organic revenue growth was 10%.
- FY2026 guidance: revenue of $5.290 billion to $5.330 billion and adjusted EPS of $27.15 to $27.55, up from prior levels.
- Company repurchased 1 million shares for $321 million in the quarter and reported 2.55x leverage.
Read the filing on SEC.gov ↗
Jul 24, 4:58 PM ET
Corpay's Compensation Committee approved special performance-based restricted stock unit grants to Ronald F. Clarke and Armando L. Netto on July 22, 2026. The awards vest only if Corpay's stock closes at or above $425.00, $450.00 or $475.00 on five separate trading days before August 31, 2028, and are meant to align their pay with shareholder stock price gains and aid retention.
- Grant date July 22, 2026; performance period runs through August 31, 2028
- Clarke received 300,000 PSUs; Netto received 28,213 PSUs
- Vesting tiers tied to stock price hurdles of $425.00, $450.00 and $475.00 on five separate trading days
Read the filing on SEC.gov ↗
May 22, 4:15 PM ET
Corpay entered into an eighteenth amendment to its credit agreement on May 21, 2026, increasing its revolving credit facility to $3.7 billion and Term Loan A to $3.3 billion, both maturing May 21, 2031, and increasing Term Loan B-6 to $2.95 billion. The company used proceeds to repay its Term Loan B-5 in full, and says the refinancing will lower annual interest expense and increase liquidity.
- Revolving credit commitments rise by $0.9 billion to $3.7 billion; Term Loan A rises by $0.4 billion to $3.3 billion, both maturing May 21, 2031
- Term Loan B-6 increases by $2.05 billion to $2.95 billion, maturing November 5, 2032
- Term Loan B-5 repaid in full using Term Loan A and revolver proceeds of $1.0 billion and Term Loan B-6 proceeds of $2.05 billion
- Company states USD interest rates are 10 basis points lower than the existing facilities
Read the filing on SEC.gov ↗
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
